VWA5A 抗体
Quick Overview for VWA5A 抗体 (ABIN7236362)
抗原
See all VWA5A 抗体适用
宿主
克隆类型
标记
应用范围
-
-
产品特性
- Polyclonal Antibody
-
纯化方法
- Affinity purification
-
免疫原
- Recombinant protein of human VWA5A
-
亚型
- IgG
-
-
anti-Von Willebrand Factor A Domain Containing 5A (VWA5A) (AA 1-786) antibody
VWA5A 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Von Willebrand Factor A Domain Containing 5A (VWA5A) (AA 1-415) antibodyVWA5A 适用: 人 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Von Willebrand Factor A Domain Containing 5A (VWA5A) (AA 332-415) antibodyVWA5A 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Von Willebrand Factor A Domain Containing 5A (VWA5A) antibodyVWA5A 适用: 人, 小鼠, 猴 WB, IF, IHC, FACS, IHC (p) 宿主: 小鼠 Monoclonal 3A3 unconjugated
anti-Von Willebrand Factor A Domain Containing 5A (VWA5A) (AA 179-228) antibodyVWA5A 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Von Willebrand Factor A Domain Containing 5A (VWA5A) (N-Term) antibodyVWA5A 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Von Willebrand Factor A Domain Containing 5A (VWA5A) (C-Term) antibodyVWA5A 适用: 人, 小鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Von Willebrand Factor A Domain Containing 5A (VWA5A) (Center) antibodyVWA5A 适用: 人, 小鼠, 大鼠, 猴 WB, IF, IC 宿主: 兔 Polyclonal unconjugated
anti-Von Willebrand Factor A Domain Containing 5A (VWA5A) (N-Term) antibodyVWA5A 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 马 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- IHC 1:100-1:300
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.9 mg/mL
-
缓冲液
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- VWA5A (Von Willebrand Factor A Domain Containing 5A (VWA5A))
-
别名
- VWA5A
-
背景
- VWA5A (von Willebrand factor A domain containing 5A), also known as BCSC-1 (breast cancer suppressor candidate 1) or LOH11CR2A (loss of heterozygosity 11 chromosomal region 2 gene A protein), is a 786 amino acid protein containing one VIT domain and one VWFA domain. VWA5A is expressed at low levels in various tissues, with no expression found in 80 % of tumor cell lines. Likely acting as a tumor suppressor gene, deletion of VWA5A leads to loss of heterozygosity (LOH) in breast and ovarian tumors, and may have an important role as a potential gene therapy target. Abnormal expression of VWA5A may lead to an increase in adhesion of CNE-2L2 cells associated with an increase in expression of E-cadherin, alpha-catenin, and p53, resulting in a decrease of malignant activity in cells with ectopic expression of VWA5A.
-
UniProt
- O00534
抗原
-
